Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Vail

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Plos One|February 12, 2016
A Comparative Oncology Study of Iniparib Defines Its Pharmacokinetic Profile and Biological Activity in a Naturally-Occurring Canine Cancer ModelCorey Saba, Melissa Paoloni, Christina Mazcko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
GS-9219--a novel acyclic nucleotide analogue with potent antineoplastic activity in dogs with spontaneous non-Hodgkin's lymphomaHans Reiser, Jianying Wang, Lee Chong, et al.
Science Translational Medicine|July 15, 2021
Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockadeRavi B Patel, Reinier Hernandez, Peter Carlson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2018
NCI Comparative Oncology Program Testing of Non-Camptothecin Indenoisoquinoline Topoisomerase I Inhibitors in Naturally Occurring Canine LymphomaJenna H Burton, Christina Mazcko, Amy LeBlanc, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Plos One|February 12, 2016
A Comparative Oncology Study of Iniparib Defines Its Pharmacokinetic Profile and Biological Activity in a Naturally-Occurring Canine Cancer ModelCorey Saba, Melissa Paoloni, Christina Mazcko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
GS-9219--a novel acyclic nucleotide analogue with potent antineoplastic activity in dogs with spontaneous non-Hodgkin's lymphomaHans Reiser, Jianying Wang, Lee Chong, et al.
Science Translational Medicine|July 15, 2021
Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockadeRavi B Patel, Reinier Hernandez, Peter Carlson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2018
NCI Comparative Oncology Program Testing of Non-Camptothecin Indenoisoquinoline Topoisomerase I Inhibitors in Naturally Occurring Canine LymphomaJenna H Burton, Christina Mazcko, Amy LeBlanc, et al.
Pageof 2